首页 > 市场调查报告书 > 医疗设备

药物递输设备

市场调查报告书

商品编码

1593443

自动注射器市场规模、份额、成长分析、按应用、按技术、按给药途径、按治疗领域、按容量、按最终用户、按地区 - 行业预测，2024-2031

Auto injector Market Size, Share, Growth Analysis, By Usage, By Technology, By Route of Administration, By Therapy Area, By Volume, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月13日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球自动注射器市场规模为71.6亿美元，从2023年的83.7亿美元成长到2031年的245.9亿美元，在预测期内（2024-2031年）预计复合年增长率为14.42。

由于慢性病盛行率上升、自我管理设备需求增加以及技术不断进步等几个关键因素，全球自动注射器市场正在强劲成长。自动注射器有助于精确输送药物，例如治疗过敏反应的肾上腺素和治疗糖尿病的胰岛素，具有使用者友好的操作、精确的剂量和提高患者对治疗通讯协定。市场上的着名参与者包括製药公司、医疗设备製造商和技术创新公司，它们都透过专注于设计、安全性和处理各种药物的能力等产品属性来争夺市场占有率。此外，法律规范、报销政策和专利保护等关键市场动态在塑造竞争格局方面发挥重要作用。尤其是美国自动注射器市场，预计在未来几年将保持持续的年复合成长率（CAGR），这反映出这些设备在医疗保健环境中的接受度不断提高。这项扩展凸显了自动注射器正在被公认为有效疾病管理的重要工具，最终透过改善治疗结果和医疗保健的自主权来使患者受益。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

SHL Medical AG
Ypsomed AG
Becton, Dickinson and Company（BD）
EQT IX（Recipharm AB）
West Pharmaceutical Services, Inc.
Molex（Phillips-Medisize）
Halozyme, Inc.
Owen Mumford Ltd.
AbbVie Inc.
Amgen Inc.
Novo Holdings A/S
Johnson & Johnson
Sanofi
GSK PLC
Gerresheimer AG
Medmix（Haselmaier）
SMC Ltd.（Oval Medical Technologies Ltd.）
Kaleo, Inc.
Solteam Incorporation Co., Ltd.
Elcam Drug Delivery Devices
Crossject
Jabil Inc.
Congruence Medical Solutions LLC
Midas Pharma GmbH

简介目录

Product Code: SQMIG35B2104

Global Autoinjectors Market size was valued at USD 7.16 billion in 2022 and is poised to grow from USD 8.37 billion in 2023 to USD 24.59 billion by 2031, growing at a CAGR of 14.42% during the forecast period (2024-2031).

The global auto injector market is witnessing robust growth driven by several key factors, including the rising incidence of chronic diseases, an elevated demand for self-administration devices, and ongoing technological advancements. Auto injectors, which facilitate the precise delivery of medications such as epinephrine for allergic reactions and insulin for diabetes management, provide significant advantages including user-friendly operation, accurate dosing, and enhanced patient adherence to treatment protocols. Notable players in the market encompass pharmaceutical firms, medical device manufacturers, and technology innovators, who vie for market share by focusing on product attributes like design, safety, and the ability to accommodate diverse medications. Additionally, crucial market dynamics-such as regulatory frameworks, reimbursement policies, and patent protections-play a significant role in shaping the competitive landscape. In particular, the U.S. auto injector market is forecasted to maintain a sustainable compound annual growth rate (CAGR) in the upcoming years, reflecting a growing acceptance of these devices in healthcare settings. This expansion underscores the increasing recognition of auto injectors as essential tools for effective disease management, ultimately benefiting patients through improved therapeutic outcomes and autonomy in their healthcare routines.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Autoinjectors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Autoinjectors Market Segmental Analysis

Global Autoinjectors Market is segmented by Usage, Technology, Route of Administration, Therapy Area, Volume, End User and Region. Based on Usage, the market is segmented into Disposable Autoinjectors, Reusable Autoinjectors. Based on Technology, the market is segmented into Manual Autoinjectors, Automatic Autoinjectors. Based on Route of Administration, the market is segmented into Subcutaneous, Intramuscular, Intravenous. Based on Therapy Area, the market is segmented into Rheumatoid Arthritis, Diabetes, Multiple Sclerosis, Anaphylaxis, Obesity, Other Therapy Areas. Based on Volume, the market is segmented into Up To 3ml, and Above 3ml. Based on End User, the market is segmented into Home Care Settings, Hospitals & Clinics, Ambulatory Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Autoinjectors Market

The rising incidence of chronic diseases, including rheumatoid arthritis, multiple sclerosis, diabetes, and allergies, serves as a pivotal market driver for the global autoinjectors market. As these conditions become increasingly prevalent, the demand for self-administration of medications is accelerating, highlighting the convenience and efficiency that autoinjectors provide. These devices empower patients, allowing for timely and accurate medication delivery, thereby enhancing treatment adherence and overall health outcomes. Moreover, the technological advancements in autoinjectors-such as needle safety features and user-friendly designs-further bolster their appeal, positioning them as essential tools for chronic disease management in an ever-evolving healthcare landscape.

Restraints in the Global Autoinjectors Market

The high cost of autoinjector devices serves as a significant market restraint, especially in emerging economies where access to healthcare solutions is often dictated by affordability. Patients in these regions may find the price point of autoinjectors prohibitive, leading to reluctance in adoption compared to more traditional and economically viable alternatives like syringes. This disparity not only limits the market potential for autoinjector manufacturers but also poses challenges for healthcare providers seeking to implement innovative treatment options. Consequently, the financial barrier associated with these advanced delivery systems can impede market growth and patient access, hindering the overall expansion of the global autoinjectors market.

Market Trends of the Global Autoinjectors Market

The Global Autoinjectors market is experiencing a significant trend towards self-administration of medications, driven by a growing patient preference for autonomy and convenience in treatment management. As patients increasingly seek to take control of their healthcare, the adoption of autoinjectors is on the rise, offering an efficient and user-friendly means to administer medications accurately. This empowerment fosters adherence to treatment regimens and enhances patient satisfaction. Furthermore, advancements in technology and design, coupled with an expanding range of therapies requiring autoinjectors, are anticipated to propel market growth, making it a pivotal segment in the broader healthcare landscape.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Supply Chain Analysis
Technology Analysis
Patent Analysis
Pricing Analysis
Trade Analysis
Customer & Buying Criteria Analysis
Regulatory landscape

Auto injector Market, By Usage

Market Overview
Disposable Autoinjectors
Reusable Autoinjectors

Auto injector Market, By Technology

Market Overview
Manual Autoinjectors
Automatic Autoinjectors

Auto injector Market, By Route Of Administration

Market Overview
Subcutaneous
Intramuscular
Intravenous

Auto injector Market, By Therapy Area

Market Overview
Rheumatoid Arthritis
Diabetes
Multiple Sclerosis
Anaphylaxis
Obesity
Other Therapy Areas

Auto injector Market, By Volume

Market Overview
Up To 3ml
Above 3ml

Auto injector Market, By End User

Market Overview
Home Care Settings
Hospitals & Clinics
Ambulatory Care Settings

Auto injector Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

SHL Medical AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EQT IX (Recipharm AB)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
West Pharmaceutical Services, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molex (Phillips-Medisize)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Halozyme, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Owen Mumford Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Holdings A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GSK PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gerresheimer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medmix (Haselmaier)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SMC Ltd. (Oval Medical Technologies Ltd.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaleo, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solteam Incorporation Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elcam Drug Delivery Devices
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Crossject
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jabil Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Congruence Medical Solutions LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Midas Pharma GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments